Compared to single-target and 38BM CAR-Ts, BM38 CAR-Ts exhibited stronger cytotoxicity and released more interferon γ when coincubated with BCMA+CD38+ MM cells (Fig. 1e–f). This evidence concerns the gene CD38 and Miyoshi myopathy.